Literature DB >> 28606795

Endothelium-Independent Primitive Myxoid Vascularization Creates Invertebrate-Like Channels to Maintain Blood Supply in Optic Gliomas.

Matija Snuderl1, Guoan Zhang2, Pamela Wu3, Tara S Jennings4, Seema Shroff4, Valerio Ortenzi4, Rajan Jain5, Benjamin Cohen6, Jason J Reidy7, Mitchell S Dushay8, Jeffrey H Wisoff9, David H Harter9, Matthias A Karajannis10, David Fenyo3, Thomas A Neubert2, David Zagzag11.   

Abstract

Optic gliomas are brain tumors characterized by slow growth, progressive loss of vision, and limited therapeutic options. Optic gliomas contain various amounts of myxoid matrix, which can represent most of the tumor mass. We sought to investigate biological function and protein structure of the myxoid matrix in optic gliomas to identify novel therapeutic targets. We reviewed histological features and clinical imaging properties, analyzed vasculature by immunohistochemistry and electron microscopy, and performed liquid chromatography-mass spectrometry on optic gliomas, which varied in the amount of myxoid matrix. We found that although subtypes of optic gliomas are indistinguishable on imaging, the microvascular network of pilomyxoid astrocytoma, a subtype of optic glioma with abundant myxoid matrix, is characterized by the presence of endothelium-free channels in the myxoid matrix. These tumors show normal perfusion by clinical imaging and lack histological evidence of hemorrhage organization or thrombosis. The myxoid matrix is composed predominantly of the proteoglycan versican and its linking protein, a vertebrate hyaluronan and proteoglycan link protein 1. We propose that pediatric optic gliomas can maintain blood supply without endothelial cells by using invertebrate-like channels, which we termed primitive myxoid vascularization. Enzymatic targeting of the proteoglycan versican/hyaluronan and proteoglycan link protein 1 rich myxoid matrix, which is in direct contact with circulating blood, can provide novel therapeutic avenues for optic gliomas of childhood.
Copyright © 2017 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28606795      PMCID: PMC5530906          DOI: 10.1016/j.ajpath.2017.04.004

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  40 in total

1.  Count-based differential expression analysis of RNA sequencing data using R and Bioconductor.

Authors:  Simon Anders; Davis J McCarthy; Yunshun Chen; Michal Okoniewski; Gordon K Smyth; Wolfgang Huber; Mark D Robinson
Journal:  Nat Protoc       Date:  2013-08-22       Impact factor: 13.491

Review 2.  Evolution of angiogenesis.

Authors:  Ramón Muñoz-Chápuli
Journal:  Int J Dev Biol       Date:  2011       Impact factor: 2.203

Review 3.  Structure and function of the interphotoreceptor matrix surrounding retinal photoreceptor cells.

Authors:  Makoto Ishikawa; Yu Sawada; Takeshi Yoshitomi
Journal:  Exp Eye Res       Date:  2015-04       Impact factor: 3.467

Review 4.  Versican and the regulation of cell phenotype in disease.

Authors:  Thomas N Wight; Michael G Kinsella; Stephen P Evanko; Susan Potter-Perigo; Mervyn J Merrilees
Journal:  Biochim Biophys Acta       Date:  2014-01-05

5.  Apolipoprotein E is synthesized in the retina by Müller glial cells, secreted into the vitreous, and rapidly transported into the optic nerve by retinal ganglion cells.

Authors:  A Amaratunga; C R Abraham; R B Edwards; J H Sandell; B M Schreiber; R E Fine
Journal:  J Biol Chem       Date:  1996-03-08       Impact factor: 5.157

6.  PSICQUIC and PSISCORE: accessing and scoring molecular interactions.

Authors:  Bruno Aranda; Hagen Blankenburg; Samuel Kerrien; Fiona S L Brinkman; Arnaud Ceol; Emilie Chautard; Jose M Dana; Javier De Las Rivas; Marine Dumousseau; Eugenia Galeota; Anna Gaulton; Johannes Goll; Robert E W Hancock; Ruth Isserlin; Rafael C Jimenez; Jules Kerssemakers; Jyoti Khadake; David J Lynn; Magali Michaut; Gavin O'Kelly; Keiichiro Ono; Sandra Orchard; Carlos Prieto; Sabry Razick; Olga Rigina; Lukasz Salwinski; Milan Simonovic; Sameer Velankar; Andrew Winter; Guanming Wu; Gary D Bader; Gianni Cesareni; Ian M Donaldson; David Eisenberg; Gerard J Kleywegt; John Overington; Sylvie Ricard-Blum; Mike Tyers; Mario Albrecht; Henning Hermjakob
Journal:  Nat Methods       Date:  2011-06-29       Impact factor: 28.547

7.  A hyaluronan binding link protein gene family whose members are physically linked adjacent to chondroitin sulfate proteoglycan core protein genes: the missing links.

Authors:  Andrew P Spicer; Adriane Joo; Rodney A Bowling
Journal:  J Biol Chem       Date:  2003-03-27       Impact factor: 5.157

8.  Differential role of tissue factor pathway inhibitors 1 and 2 in melanoma vasculogenic mimicry.

Authors:  Wolfram Ruf; Elisabeth A Seftor; Ramona J Petrovan; Robert M Weiss; Lynn M Gruman; Naira V Margaryan; Richard E B Seftor; Yohei Miyagi; Mary J C Hendrix
Journal:  Cancer Res       Date:  2003-09-01       Impact factor: 12.701

9.  Vascular Mimicry: Concepts and Implications for Anti-Angiogenic Therapy.

Authors:  James M Dunleavey; Andrew C Dudley
Journal:  Curr Angiogenes       Date:  2012-06-01

10.  Demonstrating circulation in vasculogenic mimicry patterns of uveal melanoma by confocal indocyanine green angiography.

Authors:  S Frenkel; I Barzel; J Levy; A Y Lin; D-U Bartsch; D Majumdar; R Folberg; J Pe'er
Journal:  Eye (Lond)       Date:  2007-03-16       Impact factor: 3.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.